Clinical Pathology-Hematology Department, Faculty of Medicine Ain Shams Research Institute (MASRI), Ain Shams University, Abbassia, 11566, Cairo, Egypt.
Pediatrics Hematology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ann Hematol. 2021 Dec;100(12):2909-2917. doi: 10.1007/s00277-021-04639-0. Epub 2021 Aug 25.
Tissue iron overload is a life-threatening scenario in children with transfusion-dependent β-thalassemia major, miRNAs that are involved in iron hemostasis could serve as therapeutic targets for control of iron overload. We aimed to find out the association between three iron-related miRNAs "miR-let-7d, miR-122, and miR-200b" and excess iron in tissues, in transfusion-dependent β-thalassemia major patients. Circulating miRNA expressions are measured in peripheral blood (PB) samples using qPCR of transfusion-dependent (TDT) β-thalassemia patients (n = 140) and normalized to non-transfusion-dependent (NTDT) β-thalassemia (n = 45). Results revealed that plasma expression levels of miR-let-7d and miR-200b were significantly downregulated in TDT patients; however, miR-122 was upregulated. In terms of tissue iron load, aberrant expression of miRNAs was significantly associated with increased-iron accumulation in hepatic and cardiac tissues. We concluded that circulating miRNAs are strong candidates that associate iron hemostasis in transfusion-dependent β-thalassemia major patients. And by extension, targeting miR-let-7d, miR-122, and miR-200 might serve as novel sensitive, specific and non-invasive predictor biomarkers for cellular damage under condition of tissue iron excess.
组织铁过载是输血依赖型β-地中海贫血儿童的生命威胁,参与铁止血的 miRNA 可以作为控制铁过载的治疗靶点。我们旨在研究三种与铁相关的 miRNA(miR-let-7d、miR-122 和 miR-200b)与输血依赖型β-地中海贫血患者组织中多余铁之间的关联。使用 qPCR 测量外周血(PB)样本中循环 miRNA 的表达,对输血依赖型(TDT)β-地中海贫血患者(n=140)和非输血依赖型(NTDT)β-地中海贫血患者(n=45)进行归一化。结果表明,TDT 患者血浆中 miR-let-7d 和 miR-200b 的表达水平显著下调,而 miR-122 则上调。就组织铁负荷而言,miRNA 的异常表达与肝和心脏组织中铁的积累增加显著相关。我们得出结论,循环 miRNA 是与输血依赖型β-地中海贫血患者铁止血相关的强有力候选物。并且可以扩展,针对 miR-let-7d、miR-122 和 miR-200 可能作为组织铁过载情况下细胞损伤的新型敏感、特异和非侵入性预测生物标志物。